Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALGN Align Technology	$180.11 +0.9%	$171.27	$141.74 ▼ $271.59	$13.06B	1.68	920,104 shs	884,552 shs
EW Edwards Lifesciences	$76.64 +0.6%	$72.97	$58.93 ▼ $95.25	$44.96B	1.12	5.16 million shs	6.04 million shs
ISRG Intuitive Surgical	$552.41 +0.4%	$513.67	$396.15 ▼ $616.00	$197.99B	1.7	1.65 million shs	1.01 million shs
STE STERIS	$245.03 -0.5%	$227.52	$200.98 ▼ $252.79	$24.07B	0.96	543,873 shs	525,887 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALGN Align Technology	+4.54%	-2.21%	-2.62%	-6.62%	-30.15%
EW Edwards Lifesciences	+1.49%	-2.21%	+0.05%	+5.75%	-13.50%
ISRG Intuitive Surgical	+1.97%	-1.25%	+6.92%	-5.29%	+35.90%
STE STERIS	+1.27%	-1.63%	+9.46%	+10.46%	+7.47%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALGN Align Technology	4.8606 of 5 stars	4.3	5.0	0.0	3.8	4.0	1.7	1.3
EW Edwards Lifesciences	4.5711 of 5 stars	2.2	5.0	0.0	4.0	3.5	2.5	2.5
ISRG Intuitive Surgical	4.2999 of 5 stars	2.4	3.0	0.0	4.0	4.2	2.5	1.9
STE STERIS	4.5448 of 5 stars	2.4	5.0	3.3	3.8	3.0	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALGN Align Technology	2.67	Moderate Buy	$241.25	33.95% Upside
EW Edwards Lifesciences	2.42	Hold	$80.20	4.65% Upside
ISRG Intuitive Surgical	2.75	Moderate Buy	$596.05	7.90% Upside
STE STERIS	2.71	Moderate Buy	$264.00	7.74% Upside

Current Analyst Ratings Breakdown

Latest EW, STE, ISRG, and ALGN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/22/2025	EW Edwards Lifesciences	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$84.00 ➝ $95.00
5/22/2025	ISRG Intuitive Surgical	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$590.00 ➝ $650.00
5/19/2025	STE STERIS	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$240.00 ➝ $260.00
5/16/2025	STE STERIS	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
5/16/2025	STE STERIS	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$265.00 ➝ $280.00
5/15/2025	STE STERIS	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$250.00 ➝ $250.00
5/13/2025	EW Edwards Lifesciences	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$80.00 ➝ $83.00
5/1/2025	ALGN Align Technology	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$255.00 ➝ $246.00
5/1/2025	ALGN Align Technology	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$235.00 ➝ $250.00
5/1/2025	ALGN Align Technology	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$165.00 ➝ $200.00
5/1/2025	ALGN Align Technology	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALGN Align Technology	$3.98B	3.28	$9.35 per share	19.26	$51.60 per share	3.49
EW Edwards Lifesciences	$5.52B	8.14	$2.83 per share	27.04	$11.08 per share	6.92
ISRG Intuitive Surgical	$8.71B	22.72	$7.28 per share	75.93	$46.41 per share	11.90
STE STERIS	$5.46B	4.41	$15.58 per share	15.73	$65.43 per share	3.74

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALGN Align Technology	$421.36M	$5.49	32.11	20.12	2.24	10.54%	13.84%	8.51%	7/23/2025 (Estimated)
EW Edwards Lifesciences	$4.17B	$7.00	11.00	27.87	4.82	72.93%	19.40%	14.37%	7/23/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$6.82	86.18	72.40	5.85	27.81%	14.55%	12.88%	7/17/2025 (Estimated)
STE STERIS	$378.24M	$6.20	52.02	24.68	N/A	8.66%	13.91%	8.64%	8/5/2025 (Estimated)

Latest EW, STE, ISRG, and ALGN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q4 2025	STE STERIS	$2.59	$2.74	+$0.15	$1.47	$1.47 billion	$1.48 billion
4/30/2025	Q1 2025	ALGN Align Technology	$2.00	$2.13	+$0.13	$1.27	$977.90 million	$979.26 million
4/23/2025	Q1 2025	EW Edwards Lifesciences	$0.60	$0.64	+$0.04	$0.61	$1.40 billion	$1.41 billion
4/22/2025	Q1 2025	ISRG Intuitive Surgical	$1.71	$1.81	+$0.10	$1.92	$2.19 billion	$2.25 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALGN Align Technology	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
STE STERIS	$2.28	0.93%	+9.51%	36.77%	20 Years

Latest EW, STE, ISRG, and ALGN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/7/2025	STE STERIS	quarterly	$0.57	1.01%	6/10/2025	6/10/2025	6/26/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALGN Align Technology	N/A	1.22	1.10
EW Edwards Lifesciences	0.06	3.46	2.89
ISRG Intuitive Surgical	N/A	4.07	3.22
STE STERIS	0.32	2.13	1.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALGN Align Technology	88.43%
EW Edwards Lifesciences	79.46%
ISRG Intuitive Surgical	83.64%
STE STERIS	94.69%

Insider Ownership

Company	Insider Ownership
ALGN Align Technology	0.66%
EW Edwards Lifesciences	0.34%
ISRG Intuitive Surgical	0.70%
STE STERIS	1.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALGN Align Technology	23,200	72.49 million	74.19 million	Optionable
EW Edwards Lifesciences	17,300	586.60 million	582.19 million	Optionable
ISRG Intuitive Surgical	12,100	358.42 million	352.97 million	Optionable
STE STERIS	16,000	98.25 million	97.13 million	Optionable

EW, STE, ISRG, and ALGN Headlines

Recent News About These Companies

STERIS plc (NYSE:STE) Shares Bought by Public Employees Retirement System of Ohio

May 28 at 4:56 AM | marketbeat.com

Squarepoint Ops LLC Has $3.48 Million Stock Position in STERIS plc (NYSE:STE)

May 28 at 4:11 AM | marketbeat.com

STERIS Stock: Is Wall Street Bullish or Bearish?

May 27 at 5:08 PM | msn.com

GF Fund Management CO. LTD. Takes $509,000 Position in STERIS plc (NYSE:STE)

May 27 at 4:57 AM | marketbeat.com

2,022 Shares in STERIS plc (NYSE:STE) Bought by Waverly Advisors LLC

May 27 at 4:39 AM | marketbeat.com

Woodline Partners LP Acquires New Stake in STERIS plc (NYSE:STE)

May 27 at 4:32 AM | marketbeat.com

Man Group plc Purchases 4,357 Shares of STERIS plc (NYSE:STE)

May 26 at 3:54 AM | marketbeat.com

STERIS plc (NYSE:STE) Position Decreased by Millennium Management LLC

May 26 at 3:53 AM | marketbeat.com

Brokerages Set STERIS plc (NYSE:STE) Price Target at $264.00

May 26 at 2:41 AM | americanbankingnews.com

STERIS's SWOT analysis: infection prevention leader's stock faces challenges

May 25 at 12:09 PM | investing.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Position in STERIS plc (NYSE:STE)

May 25 at 5:07 AM | marketbeat.com

STERIS plc (NYSE:STE) Shares Sold by USS Investment Management Ltd

May 25 at 4:55 AM | marketbeat.com

Worldquant Millennium Advisors LLC Sells 23,001 Shares of STERIS plc (NYSE:STE)

May 25 at 4:54 AM | marketbeat.com

Two Sigma Advisers LP Acquires Shares of 45,547 STERIS plc (NYSE:STE)

May 25 at 4:33 AM | marketbeat.com

Royal Bank of Canada Has $34.38 Million Holdings in STERIS plc (NYSE:STE)

May 25 at 4:13 AM | marketbeat.com

STERIS plc (NYSE:STE) Receives Average Rating of "Moderate Buy" from Brokerages

May 25 at 1:47 AM | marketbeat.com

STERIS (NYSE:STE) Rating Increased to Strong-Buy at Wall Street Zen

May 24, 2025 | marketbeat.com

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 84,310 Shares of STERIS plc (NYSE:STE)

May 24, 2025 | marketbeat.com

Cetera Investment Advisers Has $1.43 Million Holdings in STERIS plc (NYSE:STE)

May 24, 2025 | marketbeat.com

Twinbeech Capital LP Grows Holdings in STERIS plc (NYSE:STE)

May 23, 2025 | marketbeat.com

Two Sigma Investments LP Buys 117,404 Shares of STERIS plc (NYSE:STE)

May 23, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
By Nathan Reiff | April 30, 2025
View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
Super Micro Computer Stock Clears New Path Higher on Saudi Orders
By Gabriel Osorio-Mazilli | May 22, 2025
View Super Micro Computer Stock Clears New Path Higher on Saudi Orders
NVIDIA Stock Surges on Bullish News: How High Could It Climb?
By Thomas Hughes | May 13, 2025
View NVIDIA Stock Surges on Bullish News: How High Could It Climb?
Broadcom Set to Surge as AI Diffusion Rule Ends
By Leo Miller | May 15, 2025
View Broadcom Set to Surge as AI Diffusion Rule Ends
D-Wave Pushes Back on Short Seller Case With Strong Earnings
By Nathan Reiff | May 14, 2025
View D-Wave Pushes Back on Short Seller Case With Strong Earnings

EW, STE, ISRG, and ALGN Company Descriptions

Align Technology NASDAQ:ALGN

$180.11 +1.56 (+0.87%)

Closing price 04:00 PM Eastern

Extended Trading

$180.23 +0.12 (+0.07%)

As of 07:16 PM Eastern

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Edwards Lifesciences NYSE:EW

$76.64 +0.42 (+0.55%)

Closing price 03:59 PM Eastern

Extended Trading

$77.51 +0.87 (+1.13%)

As of 07:58 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Intuitive Surgical NASDAQ:ISRG

$552.41 +2.22 (+0.40%)

Closing price 04:00 PM Eastern

Extended Trading

$556.75 +4.34 (+0.79%)

As of 07:57 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

STERIS NYSE:STE

$245.03 -1.17 (-0.48%)

Closing price 03:59 PM Eastern

Extended Trading

$245.07 +0.04 (+0.02%)

As of 04:24 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time